1006 Product | PROSTALEN Tablets | Exphar, pharmaceutical laboratory

PROSTALEN Tablets

Form and presentation

Box of 30 extended release tablets in PVC/aluminium blister.

Composition

Alfuzosin hydrochloride 10 mg

Indications

PROSTALEN is indicated for the treatment of the functional symptoms of benign prostatic hypertrophy (BPH). PROSTALEN is also indicated as an adjuvant therapy for the insertion of a uretral catheter associated with acute urinary retention (AUR) related to benign prostatic hyperplasia.